Publikationen in Zusammenarbeit mit Forschern von Virginia Commonwealth University (7)

2023

  1. Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia

    eLife, Vol. 12

2022

  1. Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model

    Journal of Biological Chemistry, Vol. 298, Núm. 11

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2017

  1. Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects

    Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259

2016

  1. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

    Science Signaling, Vol. 9, Núm. 410

2013

  1. Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons

    Molecular Pharmacology, Vol. 84, Núm. 2, pp. 252-260